China Foreign R&D Investments Pass US But Slowdown Looming?
This article was originally published in PharmAsia News
Executive Summary
China is said to have surpassed the US in luring foreign direct investment for R&D, with the pharmaceutical industry leading the way. However, top industry experts including RDPAC managing director Joseph Cho see caveats and the looming impact of an economic slowdown.